InsidersTradesSigma
Follow the Renalytix plc stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €576.9m. The latest transaction was reported on 13 February 2026 (Purchase). Among the most active insiders: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Renalytix plc es una empresa centrada en el desarrollo de soluciones de diagnóstico para enfermedades renales. Aprovecha tecnologías avanzadas para mejorar la gestión de pacientes con afecciones renales crónicas.